Evaluation of the Split-thickness skin graft donor-site of the elderly patients
Not Applicable
Completed
- Conditions
- skin defect
- Registration Number
- JPRN-UMIN000041418
- Lead Sponsor
- Department of Plastic and Reconstructive Surgery, Shinshu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with steroid drug, immunosuppressive drug or anticancer drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie split-thickness skin graft healing in elderly patients with skin defects?
How does split-thickness skin grafting compare to standard-of-care wound management in geriatric dermatological cases?
Are there specific biomarkers that predict donor-site healing outcomes in elderly patients undergoing split-thickness skin grafts?
What are the known adverse events associated with split-thickness skin graft donor-site management in the elderly, and how are they managed?
What combination therapies or alternative approaches are being explored alongside split-thickness skin grafts for treating skin defects in aging populations?